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Abstract 
Introduction: Patients with diabetes mellitus can exert a stronger 
inflammatory response compared to systemically healthy individuals; 
however, if this accounts true patients with periodontal disease remains 
unclear. We therefore determined salivary and  serum TNF-α and IL-6 levels 
in periodontal patients, with or without type 2 diabetes mellitus (T2D)  
Material and methods: Twenty type 2 diabetes mellitus subjects with 
periodontal disease, 21 systemically healthy subjects with periodontal 
disease and 21 healthy controls were enrolled in the study. Periodontal 
indices, HbA1c levels as well as saliva and serum TNF-α and IL-6 were 
reported.  
Results: TNF-α and IL-6 levels in the saliva were higher in type 2 diabetes 
mellitus subjects with periodontal disease  compared to systemically healthy 
subjects with periodontal disease. Healthy controls showed lower TNF-α and 
European Scientific Journal   March 2014  edition vol.10, No.9  ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
351 
IL-6 levels in the saliva than subjects with periodontal disease. The 
respective serum analysis, however, revealed only a minor impact of the type 
2 diabetes mellitus and periodontal disease on TNF-α and IL-6 levels.  
Conclusions: The data support the current hypothesis that the inflammation 
linked to periodontal disease is more severe in type 2 diabetic patients 
compared to the systemically healthy individuals.  
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Introduction 
Diabetes mellitus is considered a risk factor for periodontal disease, 
although the underlying pathologic mechanisms that explain this association 
have not been completely understood (Mealey & Oates, 2006; Monea et al., 
2012; Salvi et al., 2008). The hallmark of diabetes mellitus is hyperglycemia, 
which develops as a consequence of a lack of insulin (type 1 diabetes 
mellitus, T1D) or a resistance to insulin (type 2 diabetes mellitus, T2D). 
Hyperglycemia leads to advanced glycosylation end products (AGEs) 
(Brownlee, 1994), among which HbA1c is used for monitoring long term 
glycemic control (LeRoith & Olefsky, 2004). AGEs also affect the cells in 
many ways, one being the increase in their responsiveness to inflammatory 
signals such as those derived from gram-negative bacteria 
lipopolysaccharides (Araya et al., 2003). Thus, in diabetes mellitus, cells can 
exert a stronger inflammatory response compared to the respective controls 
in vitro.  
In support of this hypothesis, some studies showed that IL-1 
(Engebretson et al., 2004), IL-6 (Kurtis el al., 1999) and IL-8 (Engebretson 
et al., 2006) in the gingival crevicular fluid were higher in diabetic patients 
with periodontitis compared to healthy individuals with periodontitis. 
However, there is a controversy, as other studies reported similar levels of 
IL-1 (Kardesler et al., 2008) in patients with periodontitis with and without 
diabetes. This controversy remained when saliva has gained attention as a 
source for diagnostic tests (Miller et al., 2010; Yeh et al., 2010 ). For 
example, IL-6, MMP-8 and OPG levels were similar in diabetic and 
systemically healthy patients with periodontitis (Coast et al., 2010). 
Moreover, T2D was associated with an increase in IL-1β and βTG 
concentration in saliva, but independent of periodontal disease (Javed et al., 
2012). Thus, saliva has gained attention as a source for diagnostic tests. 
Neither of the studies, however, has determined the levels of TNF-α, 
which is a key mediator of inflammatory reactions, and not necessarily 
follows the expression pattern of other inflammatory cytokines such as IL-6 
(Kurtis et al., 2005). Thus there is a demand for saliva research evaluating 
the impact of diabetes on the cytokines levels in periodontal patients.  
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It was reasonable to determine inflammatory cytokines in saliva of 
periodontal patients, one cohort having T2D and the other cohort having 
normal blood glucose levels.  
  
Material and method 
Study population 
The first study group included 20 T2D subjects with periodontal 
disease, the second one 21 systemically healthy with periodontal disease 
subjects, and the third one 21 systemic and periodontal healthy controls. 
Diabetics were recruited from the Diabetes Clinic, County Hospital of Tîrgu-
Mureş, without knowing their glycemic control level, and were selected by 
periodontal examination; subjects with periodontal disease but systemically 
healthy and controls were recruited from the Department of Odontology and 
Periodontology, UMF Tîrgu-Mureş, after general and periodontal 
examination. All subjects in the study groups were informed about the 
purpose of the study and signed an informed consent. The study was 
approved by the Ethical Comity of UMF Tîrgu -Mureş. 
 
Inclusion and exclusion criteria 
Inclusion criteria for the study groups were as follows: age over 18; 
no major diabetic complications; presence of at least 20 teeth; moderate to 
severe periodontitis according to the criteria of the American Academy of 
Periodontology (Armitage, 1999); no periodontal treatment within the last 
six months; no antibiotic, corticoid  or immunosuppressive administration 
within the last six months. 
We excluded smokers and subjects that had any inflammatory disease 
within the last six months. Other additional exclusion criteria were: 
pregnancy or lactation, bleeding disorders, menstruation. 
 
Periodontal status 
Clinical examination was done using a specific algorithm, by 
registration of personal data, anamnesis information, extra- and intraoral 
examination. Periodontal status was assessed by measuring specific indices 
such as plaque index (PI) (Silness & Loe, 1964), gingival index (GI) (Loe & 
Silness, 1963), gingival bleeding index (GBI) of Ainamo et Bay (Ainamo & 
Bay, 1975), periodontal pocket depth (PD) in millimeters measured in six 
sites for each tooth and clinical attachment level  (CAL) Christgau et al., 
1998) .  
 
Sample preparation 
From each enrolled subject we collected 2 ml of un-stimulated saliva 
into a sterile tube, which was centrifuged for 3 min at 3.000 rpm and 
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clarified supernatant was filtered through a low protein binding membrane, 
separated in polyethylene recipients, then marked for identification and 
stored in the refrigerator until examination. Venous blood samples were 
obtained by venipuncture using an adequate closed system sample. Tubes 
were then centrifuged at 3,000 rpm/10 min and stored at -20oC until 
analyzed. 
 
Immunoassay 
Salivary and serum TNF-α and IL-6 levels were assessed with the 
ELISA-sandwich method using a commercially available immunoassay kits 
(OptEIA human TNF-α, Pharmingen, USA; DuoSet ELISA Development 
System, R&D Systems, USA, respectively) according to the manufacturer’s 
guidelines. Results are reported in pg/ml. 
We also determined blood glucose and glycated hemoglobin (HbA1c) 
levels for each diabetic subject, in order to evaluate the glycemic control 
level of diabetes mellitus. 
 
Statistical analysis 
The results were statistically analyzed using the Mann-Whitney U 
nonparametric test and Spearman’s correlations test. P values over 0.05 were 
considered statistically significant.  
 
Results 
Study population 
Mean age was 56.73 ± 3.38 for diabetic subjects, characteristic for 
type 2 diabetes mellitus. The diabetic subjects enrolled in the study were all 
before treated with oral antidiabetic drugs, and periodontal disease was 
determined by the time of study inclusion. HbA1c levels (8-10.5%) and 
blood glucose levels (120-200 mg/dl) showed that all the enrolled diabetic 
subjects had medium to poor glycemic control of diabetes mellitus, and some 
of them had first degree obesity, having a medium BMI value of 28.75 (table 
1). Biologic parameters of all subjects in the three study groups are described 
in table 1. 
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Table 1. Biologic parameters of subjects in study groups (T2DM= type 2 
diabetes mellitus and periodontal disease, P= healthy with 
periodontal disease, C=controls) 
 
 
Saliva and serum levels of cytokines 
Salivary TNF-α and IL-6 levels were highly elevated in 
parodontopathic diabetics compared with systemically healthy 
parodontopathic patients and controls, with a high statistic significance 
(p<0.0001) (table 2, figure 1). 
Tabel 2. Salivary IL-6 and  TNF-α variation in study groups (T2DM= 
type 2 diabetes mellitus and periodontal disease, P= healthy with periodontal 
disease, C=controls) 
 
 
Serum IL-6 levels in parodontopathic diabetics were significantly 
increased (p = 0.0144) compared to systemically healthy periodontopathic 
patients and extremely significant increased (p<0.0001) compared with 
healthy controls (table 3, figure 1). 
Serum TNF-α in diabetics with periodontal disease was significantly 
increased (p=0.0193) compared to systemically healthy perodontopathic 
patients and extremely significant increased (p=0.0003) compared with 
healthy controls (table 3, figure 1). 
 
 T2DP (n=20) P (n=21) C (n=21) 
 Mean±Std.dev. Mean±Std.dev. Mean±Std.dev. 
Age (years) 56.37±13.89 52.37±11.12 53.09±14.10 
BMI 28.90±5.38 22.01±3.19 25.06±4.74 
Glycaemia (mg/dL) 168.46±21.63 84.20±.17 82.61±15.65 
HbA1C (%) 9.02±0.84 - - 
PD (mm) 5.84±0.65 5.67±0.45 2.39±0.38 
CAL (mm) 4.30±0.97 4.23±0.82 - 
PI 2.81±0.68 2.78±0.66 0.43±0.59 
GI 2.32±0.40 2.24±0.31 0.22±0.42 
GBI (%) 0.33±0.18 0.28±0.12 - 
 T2DP  (n=20) P (n=21) C  (n=21) 
IL-6 (pg/mL)* 91.12±36.92 14.09±7.28 7.41±2.46 
TNF (pg/mL)* 62.97±27.00 10.81±7.18 4.71±1.41 
*p<0.0001, Mann-Whitney U test  
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Table 3. Serum IL-6 and TNF-α variation in study groups (T2DM= type 2 
diabetes mellitus and periodontal disease, P= healthy with periodontal 
disease, C=controls) 
 
 T2DM  (n=20) P (n=21) C (n=21) 
IL-6 (pg/mL)* 20.03 ± 6.81 16.98±2.57 11.41 ± 2.52 
TNF (pg/mL)** 11.75 ± 4.56 9.88±3.27 7.95±1.81 
*p<0.0001, **p<0.001,  Kruskal-Wallis Test (Nonparametric ANOVA) 
 
 
 
Figure 1. Box plots of the levels of serum and salivary TNF-α and IL-6 in diabetics with 
periodontitis, healthy with periodontitis and controls. 
 
Correlation of saliva and serum levels of cytokines 
A marginally statistically significant correlation between IL-6 serum 
and salivary levels (R = 0.500, p = 0.057) resulted after applying Spearman’s 
nonparametric test. (Figure 2) 
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Figure 2. Serum and salivary IL-6 correlation in diabetics with periodontal disease 
 
We found no correlations between serum IL-6 levels and age, BMI, 
glycaemia, glycated hemoglobin and serum TNF-α . 
Positive correlations with a tendency for statistical significance were 
found between salivary IL-6 levels in diabetics and the following parameters, 
after applying Spearman’s nonparametric test: age (R = 0.491, p = 0.063), 
body mass index (R = 0.456, p = 0.081), glycaemia (R = 0.465, p = 0.081) 
and glycated hemoglobin (R = 0.504, p = 0.056) (Figure 3). 
 
 
Figure 3. Correlation of salivary IL-6 with HbA1c in diabetics with periodontal disease 
 
Spearman’s nonparametric test revealed an average positive 
significant correlation between serum and salivary TNF-α levels (R = 0.674, 
p = 0.006)  (Figure 4). No significant correlation was established between 
these values and the other parameters studied. 
 
 
Figure 4. Correlation of serum and salivary TNF-α in diabetics with periodontal disease 
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Discussions 
Our results showed that salivary TNF-α and IL-6 levels in periodontal 
patients were higher in diabetic patients with periodontitis compared to 
healthy individuals with periodontitis and controls. This might be one factor 
why in the presence of similar amounts of dental plaque and calculus, 
patients with T2D and periodontal disease had more severe periodontal 
problems than healthy subjects with periodontal disease.   
In our study we measured elevated TNF-α and IL-6 levels in the 
serum of diabetic subjects versus systemically healthy parodontopathic 
subjects and controls. These concentrations were increased not only when 
compared with own systemically healthy parodontopathic subjects and 
controls, but were also higher than mean TNF-α and IL-6 values described in 
literature in patients with periodontal disease but systemically healthy (Ng et 
al., 2007; Frodge et al., 2008; Coman, 2009). This confirms the hypothesis 
that diabetes mellitus is a co-factor in the onset and evolution of periodontal 
disease. 
When we determined blood glucose and HbA1c levels, we noticed 
that all subjects had a medium to poor glycemic control, with mean values 
recorded for blood glucose level of 168.46±21.63 and 9.02±0.84 for HbA1c 
respectively. This might partially be due to the presence of periodontal 
disease, which may alter metabolic control of diabetes mellitus (Gurav, 
2012). 
 Salivary IL-6 but not TNF-α tended to correlate with blood glucose 
and HbA1c levels. The results have to be interpreted with care because of the 
small study group. 
 The clinical importance of our findings is that saliva IL-6 but also 
saliva TNF-α detection might serve as an indicator to predict the evolution of 
periodontal disease in subjects with type 2 diabetes mellitus. As a diagnostic 
fluid, saliva is yet insufficiently used in daily practice. It offers some 
advantages over serum, because of its non-invasive sampling method, which 
eliminates the need for clinicians’ special training. Furthermore, saliva 
analysis yielded values of the biochemical and immunological parameters 
comparable with those detected from blood samples (Gestenfeld et al. 2005). 
 Limitations of the study are that we included only non-smokers 
subjects, to minimize confounding variables. Further research should include 
smokers with T2D and periodontal disease, as smoking is a common habit in 
Romanian population. 
 One subject that remains to be explored is how initial periodontal 
therapy can influence salivary cytokines levels and glycemic control of T2D 
in parodontophatic patients. 
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Conclusion: 
 Our study showed elevated levels of TNF-α and Il-6 in the serum and 
especially in the saliva of diabetics with periodontal disease, significantly 
higher than in systemically healthy subjects with periodontal disease and 
controls, confirming the hypothesis that the inflammation linked to 
periodontal disease is more severe in type 2 diabetic patients compared to the 
systemically healthy individuals.  
 The results of our study regarding the presence of TNF-α and IL-6 in 
the serum and total saliva of diabetic patients allow us to conclude that saliva 
analysis is an efficient and safely enough tool for diagnosis and evaluation of 
periodontal disease progression in type 2 diabetic patients.  
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